ICOcap® is a capsule-based dry powder inhaler (DPI) with superior handling features. Along with the device, we offer formulation development support by our partner ICONOVO.
User friendly inhaler for Drug Delivery to the lung
ICOcap® is Stevanato's portfolio inhaler offered to the market. It is a device solution for pharmaceutical companies who are focusing on therapeutical disease treatments as asthma and COPD.
ICOcap - Inhaler
Watch Video
ICOcap® is a capsule-based Dry Powder Inhaler for asthma and COPD treatment. It is designed to perform as good as established inhalers on the market, offering improved handling features.
Features
Reliability due to a robust design
CE marked device
For pre-filled drug formulations in size 3 capsules
Affordable price
Low flow resistance
Only 5 injection molded parts, needles and springs
Customization
Customized colour and logo options
Capsule oriented inhorizontal or vertical position
Different capsule size
Different flow resistances of choice
Therapeutic Areas
Asthma
COPD
Further indications as Cystic Fibrosis, plumonary hypertension, Idiopathic pulmonary fibrosis, etc.
Therapeutic Areas
Asthma
COPD
Further indications as Cystic Fibrosis, plumonary hypertension, Idiopathic pulmonary fibrosis, etc.
Benefits
CE-marked
Patented One-Piece-Design: Cap remains attached when open
Support in formulation development by our partner ICONOVO
Optimized size, easy handling
Benefits
CE-marked
Patented One-Piece-Design: Cap remains attached when open
Support in formulation development by our partner ICONOVO
EN
IT
DE
JP
CN
ES
